Furosemide protective effect against airway obstruction

Area of Science:

• Pharmacology
• Respiratory Medicine
• Pulmonology

Background:

• Furosemide is a potent diuretic inhibiting renal tubule Na and K reabsorption.
• Emerging evidence highlights furosemide's protective effects against bronchospasm and airway hyperresponsiveness.
• Its complex mechanisms of action on respiratory pathways are under investigation.

Purpose of the Study:

• To explore the multifaceted pharmacological effects of furosemide on the respiratory system.
• To review the evidence for furosemide's efficacy in preventing and treating airway-related conditions.
• To understand the potential of inhaled furosemide in clinical respiratory applications.

Main Methods:

• Review of existing pharmacological studies on furosemide's effects on airways.
• Analysis of clinical data regarding furosemide's use in asthma and rhinitis.
• Investigation of proposed mechanisms of action, including electrolyte transport and inflammatory pathways.

Main Results:

• Furosemide demonstrates no acute bronchodilator effect but effectively prevents or attenuates various forms of bronchospasm.
• It reduces nasal resistance in non-allergic rhinitis and protects against allergen-induced nasal reactivity.
• Inhaled furosemide is utilized for exercise-induced asthma prevention and has shown potential in reducing experimentally induced dyspnea.

Conclusions:

• Furosemide possesses significant anti-bronchospastic and airway-protective properties beyond its diuretic action.
• Inhaled furosemide presents a promising therapeutic avenue for managing respiratory conditions like asthma and dyspnea.
• Further research into its mechanisms can enhance understanding of airway physiology and inform clinical practice.